Stockscreener 앱 받기
84.11
0.36%
-0.30
Dexcom Inc 주식(DXCM)의 최신 뉴스
DexCom, Inc. (DXCM) options chain – Yahoo Finance - Yahoo Finance Singapore
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Evercore ISI Adjusts Price Target on DexCom to $110 From $90 - marketscreener.com
Dexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4:30 p.m. Eastern Time - www.marketscreener.com
DexCom Inc (DXCM) Stock Down 4.0% -- Now Undervalued? GF Score: 95/100 - GuruFocus
DexCom Falls as Investors Appear to Take Profits Ahead of Earnings - Quiver Quantitative
DexCom Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading - Business Wire
Dexcom Launches Largest Dexcom U Program Season Yet, Supporting College Athletes with Diabetes (DXCM) - GuruFocus
DexCom Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
DexCom stock gains 1.22 percent ahead of October earnings - AD HOC NEWS
Continuous Glucose Monitoring Market Size, Share [2026-2034] - Fortune Business Insights
Dexcom Hit With New Lawsuits Over G7 Monitor Failures - Medical Device and Diagnostic industry
DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care - Zacks Investment Research
DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care - TradingView
DexCom (NASDAQ:DXCM): Strong Growth Paired With a High-Quality Technical Setup - ChartMill
DXCM Maintains by RBC Capital -- Price Target Raised to $105 - GuruFocus
ShinyHunters new leak site lists O’Reilly and Dexcom breaches - cybernews.com
DEXCOM INC : RBC RAISES TARGET PRICE TO $105 FROM $90 - Moomoo
ViCentra Presents Large-Scale Real-World Evidence Demonstrating Kaleido Insulin Patch Pump System Delivers Stable Glucose Control with Very Low Hypoglycemia - GlobeNewswire Inc.
RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating - marketscreener.com
Under a preset trading plan, DexCom (DXCM) EVP Sadie Stern sells 2,565 shares. - Stock Titan
Here's Why DexCom (DXCM) is a Strong Growth Stock - Zacks Investment Research
Why DexCom Could Be the Big Winner Out of Oura’s IPO - Barron's
Dexcom Data Points to a CGM Awareness Gap, and Room to Grow - Medical Product Outsourcing
The Insider Report: The Leaders Have Taken Off - Benzinga
Dexcom Publishes New Report During Easd 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care - marketscreener.com
Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care - Dexcom Investor Relations
Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care - The Joplin Globe
Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care - Business Wire
Dexcom stock slips 2.01 percent ahead of the open - AD HOC NEWS
DexCom (DXCM) Stock Looks Cheap Based On Future Cash Flow - Yahoo Finance
DexCom stock trades below its 52-week high as Truist lifts target - AD HOC NEWS
Dexcom stock falls 1.1 percent ahead of the open - AD HOC NEWS
DexCom, Inc. (DXCM) latest stock news and headlines - uk.finance.yahoo.com
DexCom (DXCM) Promotes Former CFO Jereme Sylvain To Chief Operating Officer - Yahoo Finance
DexCom Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DexCom, Inc. (DXCM) Stock Price, News, Quote & History - Yahoo! Finance Canada
GlucoGuard, a Division of American Diversified Holdings (ADHC), Has Completed an Investors Deck Focused on Funding Research Required for FDA Approval - ACCESS Newswire
American Diversified Holdings Corporation (ADHC) Seeks Funding; Advances Dexcom App Integration - TradingView
GlucoGuard, a Division of American Diversified Holdings (ADHC), Has Completed an Investors Deck Focused on Funding Research Required for FDA Approval - TradingView
Dexcom stock heads into the open after Nasdaq gains 0.45 percent - AD HOC NEWS
DexCom, Inc. (DXCM) Stock Analysis: Strong Buy Ratings and Promising Growth in the Medical Device Sector - DirectorsTalk Interviews
Dexcom Inc. stock gains on leadership change and strong recent performance - AD HOC NEWS
Dexcom Inc. stock gains on fresh Truist and TD Cowen price targets - AD HOC NEWS
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating - Yahoo Finance
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Dexcom, Inc. Announces Appointment of Jereme Sylvain as Executive Vice President and Chief Operating Officer, Effective September 14, 2026 - marketscreener.com
Dexcom Promotes Jereme Sylvain to Chief Operating Officer - Yahoo Finance
2.37%
0.25%
자본화:
|
볼륨(24시간):